Over the past few decades, protein analysis and proteomics have emerged as crucial tools in disease risk assessment, providing a more holistic understanding of susceptibility to diseases and disease progression. During this webinar, you will learn how Olink used protein measurements and longitudinal healthcare data from a new UKB dataset from 50,000 individuals to estimate the effects of nearly 3,000 proteins on the future risk of more than 100 diseases. The full results from this analysis are available as an open-access downloadable resource, allowing you to easily annotate, search, and export disease risk associations for your biomarkers of interest. Data presentation will be followed by a demonstration of Olink Insight, our open-access, online knowledge, and analytics portal, to get a quick and friendly access to these data. Don't miss this opportunity to harness the power of this unique dataset to advance your disease research.

 

Register now to: